Literature DB >> 22102266

Piecing together the humoral and cellular mechanisms of immune thrombocytopenia.

Lisa J Toltl1, Ishac Nazi, Reza Jafari, Donald M Arnold.   

Abstract

The precise mechanisms leading to platelet-targeted autoimmunity in immune thrombocytopenia (ITP) are not known. Cellular checkpoints normally regulate immunological self-reactivity during the development of B and T cells through cell deletion, receptor editing, induction of anergy, and extrinsic cellular suppression. When these checkpoints fail, tolerance to self-antigens may be lost. In this review, we summarize the various immune mechanisms contributing to the development of ITP and relate them back to the checkpoint model of autoimmunity. These mechanisms, including increased levels of lymphocyte growth factors, resistance to death signals, and loss of T-regulatory function, result in an environment permissive to the development of platelet-reactive B and T cells. The mechanisms that lead to thrombocytopenia once tolerance for platelet antigens is lost are examined, including complement-dependent and apoptotic pathways. An improved understanding of ITP pathogenesis will ultimately guide the development of better therapies. Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102266      PMCID: PMC3938455          DOI: 10.1055/s-0031-1291373

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  113 in total

1.  Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.

Authors:  Benjamin L Hsu; Susan M Harless; R Coleman Lindsley; David M Hilbert; Michael P Cancro
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

Review 2.  Th1 and Th2 cells in autoimmunity.

Authors:  P Druet; R Sheela; L Pelletier
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

3.  Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritis.

Authors:  W Sun; H Nie; N Li; Y C Q Zang; D Zhang; G Feng; L Ni; R Xu; S Prasad; R R Robinson; W Ho; E Sercarz; J Z Zhang
Journal:  Genes Immun       Date:  2005-05       Impact factor: 2.676

4.  Modulation of platelet caspases and life-span by anti-platelet antibodies in mice.

Authors:  Pierre F Piguet; Christian Vesin
Journal:  Eur J Haematol       Date:  2002-05       Impact factor: 2.997

5.  T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.

Authors:  Bob Olsson; Per-Ola Andersson; Margareta Jernås; Stefan Jacobsson; Björn Carlsson; Lena M S Carlsson; Hans Wadenvik
Journal:  Nat Med       Date:  2003-08-24       Impact factor: 53.440

6.  Platelet production, clearance and distribution in patients with idiopathic thrombocytopenic purpura.

Authors:  Y Isaka; J Kambayashi; K Kimura; M Matsumoto; A Uehara; K Hashikawa; T Kamada; M Imaizumi; K Ashida; H Nakayama
Journal:  Thromb Res       Date:  1990-10-15       Impact factor: 3.944

7.  Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.

Authors:  Lixin Rui; Carola G Vinuesa; Julie Blasioli; Christopher C Goodnow
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

8.  Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications.

Authors:  Dongsheng Gu; Jing Ge; Weiting Du; Feng Xue; Zhenping Chen; Haifeng Zhao; Zeping Zhou; Jie Xu; Pengxia Liu; Qinjun Zhao; Lei Zhang; Renchi Yang
Journal:  Autoimmunity       Date:  2009       Impact factor: 2.815

9.  Human immunodeficiency virus infection of megakaryocytic cells.

Authors:  M Sakaguchi; T Sato; J E Groopman
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

10.  V-region directed selection in differentiating B lymphocytes.

Authors:  F Huetz; L Carlsson; U C Tornberg; D Holmberg
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  10 in total

1.  Immune thrombocytopenia: getting back to basics.

Authors:  Donald M Arnold
Journal:  Am J Hematol       Date:  2012-07-05       Impact factor: 10.047

2.  Association of PTPN22 SNP1858 (rs2476601) and Gene SNP1123 (rs2488457) Polymorphism With Primary Immune Thrombocytopenia Susceptibility: A Meta-Analysis of Case-Control Studies and Trial Sequential Analysis.

Authors:  Haokun Tian; Weikai Xu; Lequan Wen; Lirui Tang; Xinyuan Zhang; Tiangang Song; Changsen Yang; Peng Huang
Journal:  Front Genet       Date:  2022-05-25       Impact factor: 4.772

3.  Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists.

Authors:  Bahareh Ghadaki; Ishac Nazi; John G Kelton; Donald M Arnold
Journal:  Transfusion       Date:  2013-03-03       Impact factor: 3.157

Review 4.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

5.  Elevated expression of NLRP3 in patients with immune thrombocytopenia.

Authors:  Jianlin Qiao; Yun Liu; Xiaoqian Li; Yuan Xia; Yulu Wu; Depeng Li; Hongchun Li; Ping Ma; Feng Zhu; Zhenyu Li; Kailin Xu; Lingyu Zeng
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 6.  Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Authors:  Maria Vadalà; Dimitri Poddighe; Carmen Laurino; Beniamino Palmieri
Journal:  EPMA J       Date:  2017-07-20       Impact factor: 6.543

7.  Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia.

Authors:  Zhenhua Zhao; Lei Yang; Guohua Yang; Yun Zhuang; Xifeng Qian; Xin Zhou; Dajiang Xiao; Yunfeng Shen
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

8.  All-trans retinoic acid protects mesenchymal stem cells from immune thrombocytopenia by regulating the complement-interleukin-1β loop.

Authors:  Xiaolu Zhu; Yanan Wang; Qian Jiang; Hao Jiang; Jin Lu; Yazhe Wang; Yuan Kong; Yingjun Chang; Lanping Xu; Jun Peng; Ming Hou; Xiaojun Huang; Xiaohui Zhang
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

9.  Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia.

Authors:  Na Li; Nancy M Heddle; Ishac Nazy; John G Kelton; Donald M Arnold
Journal:  Blood Adv       Date:  2021-10-26

10.  Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study.

Authors:  Xiao-Lu Zhu; Ru Feng; Qiu-Sha Huang; Mei-Ying Liang; Ming Jiang; Hui Liu; Yi Liu; Hong-Xia Yao; Lei Zhang; Shen-Xian Qian; Tong-Hua Yang; Jing-Yu Zhang; Xu-Liang Shen; Lin-Hua Yang; Jian-Da Hu; Ren-Wei Huang; Zhong-Xing Jiang; Jing-Wen Wang; Hong-Yu Zhang; Zhen Xiao; Si-Yan Zhan; Hui-Xin Liu; Xing-Lin Wang; Ying-Jun Chang; Yu Wang; Yuan Kong; Lan-Ping Xu; Kai-Yan Liu; Xiao-Hong Zhang; Cheng-Hong Yin; Yue-Ying Li; Qian-Fei Wang; Jian-Liu Wang; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  Ther Adv Hematol       Date:  2022-04-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.